Bryan Goldman
About
Bryan Goldman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Bryan Goldman has authored 66 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 21 papers in Surgery. Recurrent topics in Bryan Goldman's work include Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (11 papers) and Esophageal Cancer Research and Treatment (10 papers). Bryan Goldman is often cited by papers focused on Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (11 papers) and Esophageal Cancer Research and Treatment (10 papers). Bryan Goldman collaborates with scholars based in United States, Canada and Norway. Bryan Goldman's co-authors include Charles D. Blanke, Jacqueline Benedetti, Cecilia M. Fenoglio‐Preiser, Scott A. Hundahl, Daniel G. Haller, James A. Martenson, J. Milburn Jessup, Jaffer A. Ajani, Leonard L. Gunderson and Primo N. Lara and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.
In The Last Decade
Bryan Goldman
65 papers receiving 3.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Bryan Goldman United States | 31 | 1.7k | 1.3k | 970 | 565 | 543 | 66 | 3.5k | ||
| Takuo Hayashi Japan | 30 | 1.4k 0.8× | 967 0.8× | 725 0.7× | 632 1.1× | 379 0.7× | 211 | 2.9k | ||
| Stefan Mönig Germany | 36 | 1.9k 1.1× | 862 0.7× | 1.8k 1.8× | 770 1.4× | 335 0.6× | 153 | 3.5k | ||
| M. Leader Ireland | 29 | 946 0.6× | 1.0k 0.8× | 576 0.6× | 691 1.2× | 288 0.5× | 161 | 2.8k | ||
| Chao‐Hui Zheng China | 33 | 2.6k 1.5× | 1.2k 0.9× | 1.6k 1.7× | 928 1.6× | 767 1.4× | 276 | 4.3k | ||
| Toshiaki Tanaka Japan | 30 | 723 0.4× | 1.9k 1.5× | 1.3k 1.4× | 546 1.0× | 378 0.7× | 217 | 3.3k | ||
| Katie S. Nason United States | 31 | 1.6k 0.9× | 740 0.6× | 2.2k 2.3× | 251 0.4× | 338 0.6× | 78 | 3.6k | ||
| Justin Cates United States | 35 | 1.5k 0.9× | 1.1k 0.9× | 743 0.8× | 1.1k 1.9× | 433 0.8× | 153 | 3.8k | ||
| Chang‐Ming Huang China | 34 | 2.8k 1.7× | 1.4k 1.1× | 1.8k 1.9× | 1.1k 1.9× | 865 1.6× | 326 | 5.0k | ||
| Jian‐Wei Xie China | 34 | 3.0k 1.8× | 1.4k 1.1× | 1.8k 1.9× | 937 1.7× | 761 1.4× | 307 | 5.0k | ||
| John A. Chabot United States | 41 | 964 0.6× | 2.6k 2.0× | 2.0k 2.0× | 605 1.1× | 616 1.1× | 168 | 4.3k |
Countries citing papers authored by Bryan Goldman
Since
Specialization
Citations
This map shows the geographic impact of Bryan Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Goldman more than expected).
Fields of papers citing papers by Bryan Goldman
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Bryan Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Goldman. The network helps show where Bryan Goldman may publish in the future.
Co-authorship network of co-authors of Bryan Goldman
This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Goldman. A scholar is included among the top collaborators of Bryan Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Goldman. Bryan Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cook, James R., Bryan Goldman, Raymond R. Tubbs, et al.. (2014). Clinical Significance of MYC Expression and/or “High-grade” Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas. The American Journal of Surgical Pathology. 38(4). 494–501.
2.
Goldman, Bryan, Matejka Rebolj, Carsten Rygaard, et al.. (2013). Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark. Vaccine. 31(12). 1604–1609.
3.
Smalley, Stephen R., Jacqueline Benedetti, Daniel G. Haller, et al.. (2012). Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection. Journal of Clinical Oncology. 30(19). 2327–2333.
4.
Tomblyn, Michael, Bryan Goldman, Charles R. Thomas, et al.. (2012). Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414). Journal of Thoracic Oncology. 7(5). 906–912.
5.
Kirschbaum, Mark, Bryan Goldman, Jasmine Zain, et al.. (2011). A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517. Leukemia & lymphoma. 53(2). 259–262.
6.
Bohanes, Pierre, Bryan Goldman, Jacqueline Benedetti, et al.. (2011). Association of excision repair cross-complementation group 1 (ERCC1) gene expression (GE) with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative study (SWOG 0356).. Journal of Clinical Oncology. 29(4_suppl). 2–2.
7.
Dorff, Tanya B., Bryan Goldman, Jacek Pinski, et al.. (2010). Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer. Clinical Cancer Research. 16(11). 3028–3034.
8.
Goldman, Bryan, Michael LeBlanc, James R. Cook, et al.. (2009). Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study. Annals of Oncology. 21(6). 1196–1202.
9.
Sonpavde, Guru, Bryan Goldman, V. O. Speights, et al.. (2009). Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy. Cancer. 115(18). 4104–4109.
10.
Beer, Tomasz M., Bryan Goldman, Timothy W. Synold, et al.. (2008). Southwest Oncology Group Phase II Study of Ispinesib in Androgen-Independent Prostate Cancer Previously Treated with Taxanes. Clinical Genitourinary Cancer. 6(2). 103–109.
11.
Beer, Tomasz M., Bryan Goldman, Craig R. Nichols, et al.. (2008). Southwest Oncology Group Phase II Study of Irinotecan in Patients with Advanced Transitional Cell Carcinoma of the Urothelium that Progressed After Platinum-Based Chemotherapy. Clinical Genitourinary Cancer. 6(1). 36–39.
12.
Goldman, Bryan, Michael LeBlanc, & John Crowley. (2008). Interim futility analysis with intermediate endpoints. Clinical Trials. 5(1). 14–22.
13.
Wolman, Sandra R., Bryan Goldman, Marilyn L. Slovak, et al.. (2007). Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study. Cancer Genetics and Cytogenetics. 176(1). 22–27.
14.
Goldman, Bryan, Primo N. Lara, Tomasz M. Beer, et al.. (2007). Clinical and molecular factors predictive of outcome with first-line sorafenib-based therapy in advanced renal carcinoma (RCC): An analysis of SWOG 0412. Journal of Clinical Oncology. 25(18_suppl). 5108–5108.
15.
Beer, Tomasz M., Catherine M. Tangen, Maha Hussain, et al.. (2006). The prognostic value of hemoglobin change after initiating androgen‐deprivation therapy for newly diagnosed metastatic prostate cancer. Cancer. 107(3). 489–496.
16.
Seixas, Noah, et al.. (2005). Prospective noise induced changes to hearing among construction industry apprentices. Occupational and Environmental Medicine. 62(5). 309–317.
17.
Neitzel, Richard L., Noah Seixas, Bryan Goldman, & William Daniell. (2004). Contributions of Non-occupational Activities to Total Noise Exposure of Construction Workers. The Annals of Occupational Hygiene. 48(5). 463–73.
18.
Hausken, Trygve, et al.. (2001). Quantification of gastric emptying and duodenogastric reflux stroke volumes using three-dimensional guided digital color Doppler imaging. European Journal of Ultrasound. 13(3). 205–213.
19.
Vaezy, Shahram, Roy W. Martin, Peter Kaczkowski, et al.. (1999). Use of high-intensity focused ultrasound to control bleeding. Journal of Vascular Surgery. 29(3). 533–542.
20.
Hausken, Trygve, Daniel F. Leotta, Kris V. Kowdley, et al.. (1998). Estimation of the human liver volume and configuration using three-dimensional ultrasonography: effect of a high-caloric liquid meal. Ultrasound in Medicine & Biology. 24(9). 1357–1367.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Takuo Hayashi Breakdown of academic impact, for papers by Stefan Mönig Breakdown of academic impact, for papers by M. Leader Breakdown of academic impact, for papers by Chao‐Hui Zheng Breakdown of academic impact, for papers by Toshiaki Tanaka Breakdown of academic impact, for papers by Katie S. Nason Breakdown of academic impact, for papers by Justin Cates Breakdown of academic impact, for papers by Chang‐Ming Huang Breakdown of academic impact, for papers by Jian‐Wei Xie Breakdown of academic impact, for papers by John A. Chabot